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Abstract
Comprehensive analysis of the transcription start sites of the Ly49 genes of C57BL/6 mice using the oligo-capping 59-RACE
technique revealed that the genes encoding the ‘‘missing self’’ inhibitory receptors, Ly49A, C, G, and I, were transcribed
from multiple broad regions in exon 1, in the intron1/exon2 region, and upstream of exon -1b. Ly49E was also transcribed in
this manner, and uniquely showed a transcriptional shift from exon1 to exon 2 when NK cells were activated in vitro with
IL2. Remarkably, a large proportion of Ly49E transcripts was then initiated from downstream of the translational start codon.
By contrast, the genes encoding Ly49B and Q in myeloid cells, the activating Ly49D and H receptors in NK cells, and Ly49F in
activated T cells, were predominantly transcribed from a conserved site in a pyrimidine-rich region upstream of exon 1. An
,200 bp fragment from upstream of the Ly49B start site displayed tissue-specific promoter activity in dendritic cell lines,
but the corresponding upstream fragments from all other Ly49 genes lacked detectable tissue-specific promoter activity. In
particular, none displayed any significant activity in a newly developed adult NK cell line that expressed multiple Ly49
receptors. Similarly, no promoter activity could be found in fragments upstream of intron1/exon2. Collectively, these
findings reveal a previously unrecognized relationship between the pattern of transcription and the expression/function of
Ly49 receptors, and indicate that transcription of the Ly49 genes expressed in lymphoid cells is achieved in a manner that
does not require classical upstream promoters.
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Introduction
The Ly49 gene complex on mouse chromosome 6 encodes a
family of closely related type II transmembrane proteins most of
which have been shown to recognize MHC class I or class I-
related ligands [1,2]. In the C57BL/6 mouse strain there are
probably 10 functional genes, but despite their close linkage and
high degree of sequence similarity, they show quite different
patterns of expression. The four genes that encode the inhibitory
‘‘missing self’’ receptors Ly49A, C, G, and I are expressed on NK
cells, NKT cells, and activated T cells in an unusual stochastic
manner creating a complex repertoire of cells expressing different
permutations of these receptors in a pseudo-monoallelic manner
[3,4,5]. Ly49F is found predominantly on a subpopulation of
activated T cells [6], whilst Ly49E is expressed in the absence of
other Ly49s on fetal NK cells, thymic NKT cells, various
subpopulations of resting and activated cdT cells, and on activated
(but not resting) mature NK cells [7,8,9]. Whether the expression
of Ly49F is biallelic or monoallelic is unknown, but Ly49E appears
to be expressed in a stochastic and predominantly monoallelic
manner [10,11]. Expression of the two genes encoding activating
receptors, Ly49D and H, is strictly limited to NK cells, and has
been reported to occur in a non-stochastic and biallelic manner
[12,13]. The remaining two Ly49s, Ly49B and Q are expressed on
separate but partially overlapping myeloid cell populations in an
apparently non-stochastic manner [14,15].
Surface expression of Ly49 receptors correlates closely with
expression of the corresponding mRNAs. This implies that
expression is regulated predominantly at the transcriptional level
and that sequence differences within the individual genes and their
flanking regions are responsible for the different patterns of
expression. A pre-requisite for understanding the expression of
these genes, therefore, would be to establish the sites at which
transcription is initiated and the locations of regulatory sequences.
Previous studies have indicated considerable variability in the
positions of transcription start sites (TSSs) both between and
within individual Ly49 genes [16,17,18]. However, it is not clear
whether this variation is real or a consequence of RNA
degradation or the premature termination of reverse transcription
during the preparation of cDNA. Furthermore, only a few Ly49
genes have been examined. Similarly, the analysis of regulatory
sequences has been largely confined to the immediate upstream
regions of two genes encoding inhibitory receptors expressed in
NK cells, Ly49A and Ly49I, and has relied exclusively on in vitro
promoter assays in transfected EL4 cells [17,19,20,21]. In the case
of Ly49I, such studies led to the identification of a potential
repressor site upstream of the core promoter [20], but the
existence of this site in other genes has not been examined. In the
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AML1, TCF-1, and TBP upstream of exon 1 were suggested to
control expression [17,19], but puzzlingly these sites are not well
conserved even amongst the four inhibitory genes, and the
promiscuity of transcription factor binding sites has led to the
validity of this general approach being questioned [22]. By
contrast, the chance cloning of a rare Ly49G transcript led to the
identification of a distal upstream element, Pro1, that is highly
conserved amongst the inhibitory genes and which has been
reported to act as a bidirectional promoter in immature, but not
mature, NK cells [23,24].
In the present study we set out to unambiguously establish the
nature of transcriptional initiation in each of the functional Ly49
genes of C57 mice using the ‘‘oligo-capping’’ RACE technique
[25] in which an RNA oligonucleotide is ligated to the 59 end of
mRNA molecules in a reaction that is dependent on the presence
of a cap structure, thereby ensuring that only full length
undegraded RNA molecules and full length cDNA copies that
extend to the 59 end of the mRNA are captured. The results
revealed for the first time distinct variations in transcriptional
patterns that correlate with Ly49 gene expression patterns and
function. Surprisingly, only in the case of the Ly49B gene did the
regions upstream of transcriptional initiation sites display clear
tissue specific promoter activity.
Materials and Methods
Ethics statement
All animal work was approved by the UK Home Office under
licence 60-3379.
Cells and RNA
Spleen, bone-marrow, and peritoneal cells were prepared using
standard methods from normal C57BL/6 mice, or from RAG-ko
mice on a C57BL/6 background kindly provided by Dr. B.
Seddon, National Institute of Medical Research, London, the
latter serving as a source of fresh ex vivo NK cells. Cultured NK
cells, comprising .98% NK1.1
+CD3
2 cells, were obtained by
sorting fresh C57BL/6 spleen cells that displayed high levels of
staining with PE-Cy7 anti-NK1.1 (BD Biosciences) using a
FACSDiva instrument (BD Biosciences), and growing these in
DMEM containing 10% FBS and 350 ng/ml human rIL2 for ,3
weeks [26]. The D
2 NK cell line arose from a similar experiment
in which, after 5 days culture, cells were stained with the 2D9 anti-
NKRP1D mAb [27], sorted for NKRP1D
2 cells, and returned to
culture. After ,3 months, outgrowth of cells having an
NK1.1
+CD3
2 phenotype occurred, and these could be cloned
and maintained indefinitely in the above medium. Immature NK
cells, comprising .95% NK1.1
+CD3
2 cells, were generated from
day 14 fetal thymocytes as described previously [28,29]. The I2/
22 immature NK cell line was obtained by extended culture and
subsequent cloning of such cells. The LNK immature NK cell line
[23,30] was obtained from Dr. S. Anderson, NCI- Frederick, MD.
Both of these lines were grown in DMEM containing 10% FBS
and 3.5 ng/ml human rIL2. Cultured bone-marrow derived
macrophages and dendritic cells were also generated as described
previously [15]. Mouse tumour cell lines were grown in continuous
culture in DMEM with 5% FBS.
Oligo-capping RACE
The GeneRacer kit from Invitrogen was used exactly as
described by the manufacturer. Briefly, RNA prepared using
RNA Bee (Biogenesis) according to the manufacturer’s instructions
was treated with calf intestinal phosphatase to remove 59
phosphate groups, and then with tobacco acid pyrophosphatase
to remove the 59 cap structure from intact mRNA molecules,
leaving an exposed 59 phosphate group that provided the substrate
for RNA ligase mediated ligation of a GeneRacer RNA
oligonucleotide. cDNA copies were generated using random
primers so as to avoid bias towards the 39 ends, followed by
PCR amplification using the GeneRacer forward primer and an
appropriate gene specific reverse primer. This strategy ensured
that only transcripts that possessed a 59 cap structure and which
were reverse transcribed to the 59 end of the ligated oligonucle-
otide would generate PCR products [25]. Second round PCR was
performed using the GeneRacer nested primer and an internal
gene specific reverse primer. The sequences and locations of the
main primers used are shown in Table S1 and Figure S1. The
products were then cloned into pCR4-TOPO-TA (Invitrogen) and
sequenced. To avoid biases, multiple independent RACE-PCR
reactions were performed with multiple independent RNA
samples and with at least two combinations of reverse primers
for each gene. In addition, no more than two sequences that had
the same 59 start point were included from the same reaction in
the final dataset. Statistical analysis was by Fisher’s exact test.
Conventional RT-PCR
RNA prepared as above was reverse transcribed using an
oligo(dT) primer and Moloney murine leukaemia virus reverse
transcriptase (Promega) according to the manufacturer’s instruc-
tions. PCR was performed by adding cDNA prepared from equal
numbers of cells to PCR mixtures containing 200 mM dNTPs,
2 mM MgCl2, 0.1 mM forward and reverse primers, and 20 U/ml
Taq polymerase (Bioline) in NH4 buffer. Reactions were run for 40
cycles at 95uC for 1 min, 58uC for 1 min, and 72uC for 1 min,
then examined on agarose gels containing ethidium bromide. The
sequences of the primers used are given in Table S1. In
appropriate cases the amplimers were cloned into pCR4 and
sequenced.
Immunofluorescence
Cellswerestained withthefollowingmAbs,some kindlyprovided
by the investigators shown, and analysed by flow cytometry: JR9
anti-Ly49A (Dr. J. Roland, Pasteur Institute, Paris, France), SED85
anti-Ly49D (Dr. D. Raulet, University of California), CM4 anti-
Ly49E [9], HBF anti-Ly49F(BD Bioscience), 4LO3311 anti-Ly49C
(Dr. S. Lemieux, University of Quebec, Canada), 4D11 anti-Ly49G
(Dr. L. Mason, NIH, Bethesda, MD), 3D10 anti-Ly49H (Dr. H.
Smith and W. Yokoyama, Washington University School of
Medicine, St. Louis, MO), YLI-90 anti-Ly49I (BD Biosciences),
PE-Cy7 anti-NK1.1 (BD Biosciences), and eFluor660 anti-CD3
(eBioscience).
Constructs and luciferase reporter assays
The desired segments from Ly49 genes were amplified from
appropriate BACs from the RP23 and RP24 mouse and CH230
rat libraries (BACPAC Resources Center, CHORI) using primers
containing 59 EcoRV and HindIII sites and KOD HiFi
polymerase (Novagen). The HSV promoter was amplified from
the pNS vector [31] in the same manner. The mutant B-448-Inr-
GG fragment was prepared by direct gene synthesis (MWG,
Ebersberg, Germany). The products were digested with EcoRV
and HindIII and cloned into the EcoRV and HindIII sites of the
promoterless luciferase reporter vector pGL4 (Promega). The full
sequences of all of the fragments tested in this study are given in
Table S2. Plasmids were purified using Genelute kits (Sigma), and
transfected into cells using DEAE-dextran. Briefly, cells were
washed in Ca-free PBS then resuspended in AIMV medium
Ly49 Gene Transcription
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1 mg/ml DNA and 100 mg/ml DEAE-dextran for 30 min at room
temperature in a volume of 2 ml AIMV, then spun down,
resuspended in DMEM/HEPES (Sigma D6171) containing 10%
FBS, and duplicate 1 ml aliquots added to wells of 24 well plates.
In the case of the D
2 NK cells this medium also contained
350 ng/ml human rIL2. One day later, non-adherent cells were
resuspended and transferred to microfuge tubes, spun down, and
supernatant discarded. Meanwhile, 100 ml of Glow Lysis Buffer
(Promega) was added to the remaining adherent cells in each well
and, after 10 min incubation at room temperature with occasional
mixing, the lysed cells were resuspended and transferred to the cell
pellets in microfuge tubes. Following mixing, 30 ml of lysate was
mixed with 10 ml of Bright-Glo reagent (Promega) in the wells of
luminescence plates (Thermo 7705). These were loaded into a
Thermo Varioskan luminometer, and scanned after 10 min dark
adaptation. In all experiments empty pGL4 was used as a negative
control, and pGL4 containing the HSV promoter as positive
control. The luciferase activity of all samples was calculated as a
percentage of that of the positive control HSV promoter plasmid.
In a typical experiment, the control pGL4-HSV promoter
construct had reporter activity .30 fold higher than empty
Figure 1. Transcriptional start sites in Ly49 genes. The start sites of cap-trapper 59RACE cDNAs are plotted onto gene sequence alignments of
the region upstream of the exon1-intron1 boundary (A), the region surrounding the intron1-exon2 boundary (B), and exon-1b (C). Exonic regions are
shown in upper case letters, intronic regions in lower case letters. In the case of the Ly49I exon-1b region, the distinction is artificial as the intronic
region ends with a defective splice signal (highlighted in red). Black vertical bars mark sites at which .10% of all transcripts for a given gene
originated, the number of bars indicating the actual percentage in units of 10% (eg. 3 bars=30–40% of all transcripts). Asterisks show other TSSs in
these regions. A small number (,5%) of TSSs mapped outside of these egions (see text) and are therefore not shown on the diagram, but are
included in the analysis in Table 1. Bases highlighted in blue or green are the TSSs of cDNAs deposited in Genbank, those in green being from the
Riken CAP-trapper high efficiency cDNA cloning project. The red T in Ly49A is the TSS for Ly49A in EL4 cells determined by Kubo et al [16] using primer
extension and nuclease protection. Regions highlighted in purple in Ly49B and Ly49Q correspond to canonical Inr sequences, the grey region in Ly49B
corresponding to a perfectly positioned canonical DRE sequence, and the underlined bases in Ly49B corresponding to GC and TA rich regions with
similarity to BRE and TATA sequences [46]. For 9 of the 10 genes, the general disposition of TSSs in fresh cells was not different to that in cultured cells
(see Table 1), and the data has therefore been combined. However, for Ly49E the results obtained from fresh cells (Ef) and cultured cells (Ec) were
markedly different and are therefore plotted separately.
doi:10.1371/journal.pone.0018475.g001
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obtained in at least three independent experiments with each
construct. Statistical analysis was by paired t-test.
Results
Transcriptional start sites of C57 Ly49 genes
Oligo-capping 59RACE analysis of C57 Ly49 transcripts
revealed striking differences in the nature and position of their
TSSs that showed a remarkable correlation with the function and
expression pattern of the genes. A graphical representation of the
data is provided in Figure 1, with a full numerical analysis in
Table 1. The start sites of the two Ly49 genes expressed in myeloid
cells, Ly49B and Ly49Q, were highly restricted, the great majority
of transcripts originating from exon 1, and predominantly from a
highly favoured region within exon 1. In the case of Ly49B, 60% of
all transcripts initiated from a single A residue 105 bases upstream
of the exon1/intron1 boundary, and 11% initiated at an A residue
9 bases further upstream. In Ly49Q, 27% and 30% of all
transcripts initiated at the exactly homologous positions. The
dominance of these start sites in Ly49B and Ly49Q was observed in
all myeloid cell-containing populations examined including fresh
spleen cells, fresh peritoneal cells, fresh bone marrow cells,
cultured bone marrow-derived macrophages, cultured bone
marrow-derived dendritic cells, and the myeloid tumour cell line
RAW264. The genes encoding activating Ly49 receptors in C57
NK cells, Ly49D and Ly49H, also used this same homologous site
in exon 1 as the major TSS, 64% of all Ly49H transcripts and 43%
of all Ly49D transcripts beginning at the base corresponding to
that which formed the dominant TSS in Ly49B, or at the
Table 1. Summary of all RACE data
1.
Total % E-1b % E1 % I1/E2 % E2 No ATG % .E2 % No ATG
Ly49A Cultured 38 0 58 32 5 5 11
Fresh 29 0 72 28 0 0 0
Total 67 0 64 30 3 3 6
Ly49B Cultured 58 0 88 0 12 0 12
Fresh 56 0 84 0 16 0 16
Total 114 0 86 0 14 0 14
Ly49C Cultured 19 0 89 0 11 0 11
Fresh 10 0 90 0 0 10 10
Total 29 0 90 0 7 3 10
Ly49D Cultured 30 0 67 0 23 10 33
Fresh 19 0 68 0 21 11 32
Total 49 0 67 0 22 10 33
Ly49E Cultured fetal 62 0 16 31 53 0 53
Cultured adult 69 0 22 26 51 1 52
All cultured 131 0 19 28 52 1 53
Fresh 17 0 94 0 6 0 6
All fresh 17 0 94 0 6 0 6
Ly49F Cultured 15 0 93 7 0 0 0
Fresh 22 0 82 0 14 5 18
Total 37 0 86 3 8 3 11
Ly49G Cultured 39 1 13 72 3 13 15
Fresh 20 0 10 50 0 40 40
Total 59 1 12 64 2 22 24
Ly49H Cultured 37 0 95 3 0 3 3
Fresh 32 0 84 6 3 6 9
Total 69 0 90 4 1 4 6
Ly49I Cultured 25 28 60 4 8 0 8
Fresh 8 75 25 0 0 0 0
Total 33 39 52 3 6 0 6
Ly49Q Cultured 38 0 97 3 0 0 0
Fresh 23 0 96 4 0 0 0
Total 61 0 97 3 0 0 0
1For each Ly49 gene the data shows the total number of RACE cDNA clones obtained from either cultured or fresh cells, and the percentage of these that originated in
exon -1b (E-1b), exon 1 (E1), the region around the intron 1/exon 2 boundary upstream of the ATG start codon (I1/E2), in exon 2 downstream of the ATG start codon (E2
No ATG), or downstream of exon 2 (.E2), together with the total percentage of transcripts that initiated downstream of the normal translational start codon in exon 2
(% No ATG).
doi:10.1371/journal.pone.0018475.t001
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gene initiated at the corresponding homologous position, which
was also favoured, but to a lesser extent, during in vivo
transcription of Ly49E.
By contrast, amongst the four genes known to encode
inhibitory receptors in NK cells, Ly49A, C, G,a n dI, no consistent
dominant TSS was found. Instead, transcripts were initiated over
a broad region not only within exon 1 but at other sites. In
particular, 64% of Ly49G and 30% of Ly49A transcripts initiated
in a broad region around the intron1/exon2 boundary. Although
other Ly49 genes also initiated transcripts from this region the
frequency was much lower. For example, 3/62 Ly49H transcripts
began in this region compared to 20/67 Ly49A transcripts
(P=0.002). Ly49C initiation was largely confined to exon 1, but
surprisingly a large proportion (39%) of Ly49I transcripts initiated
from an LTR-like repeat sequence just upstream of exon -1b
[23]. A single Ly49G transcript was also found to start in this
region. Alignment of the regions upstream of exon -1b revealed
no obvious reason why Ly49I transcripts should so frequently
originate from this site, the Ly49I sequence being very similar to
that of Ly49C, E,a n dF (not shown).
Uniquely, in the case of Ly49E a striking difference was found
between fresh cells and cultured cells: in fresh cells 94% of
transcripts initiated in exon 1 and 0% at the intron1/exon2
boundary, but in cultured cells only 19% of transcripts initiated in
exon 1 and 28% initiated around the intron1/exon2 boundary
(P=1.3610
29). In addition, and unexpectedly, 52% of all Ly49E
transcripts in cultured NK cells initiated downstream of the ATG
translational start codon with nearly half of these initiating at a
single A residue 40 bases downstream of the start codon. No
difference in the distribution of Ly49E initiation sites was found
between immature NK cells cultured from fetal thymus and
mature NK cells cultured from adult spleen. Most other genes,
including those with dominant sites in exon 1, also initiated
transcripts from downstream of the ATG start codon in exon 2 but
at lower frequencies than Ly49E. Ly49 transcripts initiating outside
of the regions shown in Figure 1 were also found occasionally,
including ones from further upstream in exon 1, and in exons and
introns downstream of exon 2. The frequency of such transcripts is
almost certainly underestimated due to biases against long cDNAs
and the inability to detect transcripts initiating downstream of the
reverse primers used.
Analysis of sequence upstream of exon 1
The comparative structure of the 59 ends of the functional Ly49
genes in C57BL/6 mice is shown in Figure 2. All Ly49 genes show
a high degree of organizational and sequence similarity from the
start of exon 1 to downstream of exon 2. Ly49A, G, C, I, E, F, and
D also show a high degree of similarity extending .2 kb upstream
of exon 1 except that Ly49D has lost an ,350 bp region from just
downstream of exon -1b. The remaining three genes are strikingly
different in this region. In the Ly49B gene only the first ,290 bp
upstream of exon 1 shows significant homology to the consensus
Ly49 sequence. No other sequence in the region extending at least
25 kb upstream of exon 1 in the Ly49B gene displays any
significant homology to sequences found in the upstream region of
other Ly49 genes, except for repetitive elements. Most of the
immediate upstream region in the Ly49B gene is occupied by a
large block of LINE repeat sequence as noted previously [15].
Interestingly, immediately preceding this is a unique ,120 bp
sequence that has no homologue in any other Ly49 gene or
anywhere else in the mouse genome. An homologous sequence is
found in a similar position in the rat orthologue of Ly49B, Ly49i8
(not shown), but not in any other rat Ly49 gene, suggesting that
this sequence may play some role in controlling the unique pattern
of expression of Ly49B.
The Ly49Q and Ly49H genes also possess large LINE sequences
in this region, but in contrast to the Ly49B gene most of the
conserved upstream sequence found in the Ly49A, G, C, I, E, F,
and D genes is still present, albeit displaced several kb upstream
[not shown]. In the Ly49H gene the LINE sequence has been
inserted just 280 bp upstream of the dominant TSS, and just
385 bp upstream of the exon1/intron1 boundary. Thus, the only
uninterrupted upstream sequence shared by all C57BL/6 Ly49
genes is the first ,280 bp upstream of exon 1. According to
conventional gene expression models this region would be
expected to contain the core promoter elements required to drive
Ly49 gene expression.
Figure 2. Structure of the upstream region of Ly49 genes. The diagram shows the ,3.5–6 kb region that extends upstream from exon 2 to just
beyond the LTR-like repeat sequence that precedes exon -1b (except for Ly49B that lacks a recognizable exon -1b). Exons are shown in dark blue,
homologous intronic regions in light blue, LINE/SINE repeats in green, LTR-like repeats in grey, and unique sequence in purple. Dominant TSSs are
shown by red triangles, broad transcriptional initiation regions by red bars, and the translational start site by a pale blue line.
doi:10.1371/journal.pone.0018475.g002
Ly49 Gene Transcription
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no promoter activity in EL4 cells
To test this hypothesis, fragments from this region were inserted
upstream of the luciferase gene in the promoterless pGL4 vector
and transfected into EL4, a T cell lymphoma line that frequently
but not always expresses Ly49A and Ly49G [32], and which has
been used in all previous studies of Ly49 gene promoters
[17,19,20,21]. The EL4 subline we used in the initial studies was
RMA/E3 that expresses both Ly49A and Ly49G at the cell
surface (Figure 3A, left panels) and at the transcriptional level
(Figure 3B, lane 1).
The positions of the fragments tested are illustrated in Figure 4A.
We initially examined the FM fragments, which in most cases began
,430 bp upstream of the exon 1/intron 1 boundary and ended
12 bp upstream of this boundary, these sites being chosen because
they corresponded with the Fnu4HI and MspI sites used in a
previous study of the Ly49I promoter [20]. In the case of Ly49H, the
FM product began shortly before the LINE sequence, 375 bp
upstream of the exon1/intron1 boundary.OnlytheLy49A fragment
displayed substantive promoter activity, typically ,100 fold higher
than emptycontrolvector and,2 foldhigherthan thecontrolHSV
promoter (Figure 4B, dark blue bars). By comparison, the FM
fragmentsfrom mostothergenes had little orno activity,exceptthat
from Ly49E which displayed moderate activity.
The low activity of the Ly49I FM fragment agrees with previous
results obtained by Gosselin et al. [20]. However, these workers
reported that a truncated fragment of the Ly49I gene, beginning at
a PstI site ,270 bp upstream of the exon1/intron1 boundary had
significant promoter activity leading to the suggestion that the
distal part of the Ly49I FM fragment contained a repressor site. To
investigate whether the presence of such a repressor site explained
the lack of expression of other Ly49 genes, we prepared a series of
pGL4 constructs containing the shorter upstream fragments
equivalent to the PstI-MspI fragment of Ly49I (PM fragments,
see Figure 4A). However, none of these ,250 bp PM fragments,
including that prepared from Ly49I, showed increased promoter
activity compared to the longer FM fragment (Figure 4B, light
blue bars).
The relationship between promoter activity and the
expression of endogenous Ly49 genes
The high promoter activity of the Ly49A FM and PM upstream
fragments in RMA/E3 cells correlates with the expression of the
endogenous Ly49A gene in these cells. Similarly, the negligible
promoter activity of most other Ly49 upstream fragments in these
cells correlates with the lack of expression of the corresponding
endogenous genes at the protein level (data not shown) and at the
RNA level (as illustrated by the RT-PCR data for Ly49B and
Ly49Q in Figure 3B, lane 1). However, this correlation breaks
down for the Ly49G gene, whose upstream fragment displays
negligible promoter activity in RMA/E3 cells despite strong
expression of the endogenous gene at the cell surface (Figure 3A,
lower left panel) and at the RNA level (Figure 3B, lane 1).
This discrepancy might be explained if, as in NK cells,
transcription of the Ly49G gene in RMA/E3 cells is initiated
mainly at the intron1/exon2 boundary rather than upstream of
exon 1. However, RT-PCR analysis using a forward primer site in
exon 1 showed that exon 1-containing Ly49G transcripts could be
readily detected in RMA/E3 cells (Fig 3B lane 1), in line with a
previous RACE analysis that showed that most Ly49G transcripts
in these cells originated from exon 1 [33]. Furthermore, fragments
extending ,500 bp and ,800 bp upstream from just before the
start codon in exon 2 of Ly49G (uE2 fragments, see Figure 4A)
lacked detectable promoter activity in RMA/E3 cells (Figure 4C).
Similar fragments prepared from other genes, including Ly49A and
Ly49E, both of which like Ly49G frequently initiate transcription in
NK cells at the intron1/exon2 boundary, were devoid of promoter
activity, apart from some very low activity found in a fragment
from the Ly49J gene (Figure 4C) that had previously been reported
to display weak promoter activity [21]. In a further effort to
identify promoter activity in the 59 end of the Ly49G gene we
tested ‘‘Full length’’ ,2 kb constructs that began with the region
upstream of exon 1, corresponding to the site of strong promoter
activity in the Ly49A gene, and ended at various positions in exon
2 (see Figure 4A). None of these fragments had substantive
promoter activity (Figure 4D). By contrast, a similar fragment from
the Ly49A gene that ended 39 bp upstream of the start codon (A-
429-39) was as active as the control HSV promoter, and an Ly49A
fragment that ended 97 bp downstream of the start codon (A-
429+97) retained significant activity despite the fact that such a
construct would potentially add 44 amino acids to the N-terminus
of the luciferase protein (Figure 4D). Only when one additional
base was added (+98 construct), thereby causing a frame shift, was
the promoter activity of Ly49A fragments lost.
To explore more fully the relationship between the promoter
activity of upstream gene fragments and the expression of
endogenous genes, we examined other sublines of RMA EL4
cells [32]. The Ly49A FM upstream fragment displayed strong
promoter activity in the mtp2 subline [34] but only weak activity
in the in the ham2 subline [35] (Figure 5A, dark blue bars) despite
the fact that ham2 cells clearly expressed Ly49A at the cell surface
(Figure 3A, upper right panel) and were actively transcribing the
endogenous Ly49A gene (Figure 3B, lane 3). Similarly, the Ly49G
FM fragment had negligible promoter activity in all three sublines
(Figure 5A, light blue bars) despite the expression of Ly49G at the
protein and/or RNA levels in all these cells (Figure 3A and 3B).
Exactly parallel results were obtained with Ly49A and Ly49G PM
fragments (data not shown).
It could be argued that because EL4 is a T cell line that has been
grown in culture for more than 50 years, it is an inappropriate
vehicle in which to analyse the physiological expression of Ly49
receptors in NK cells. During the course of this study we succeeded
in deriving a stable long-term NK1.1
+CD3
2 NK cell line, D
2,t h a t
uniformly expressed the Ly49 receptors A, C, E, G, H, and I as
shown by RT-PCR analysis (Figure 3B, lane 4) and cell surface
staining (Figure 3C). To our knowledge this is the first NK cell line
to have been obtained fromnormal adult NK cells. Importantly, the
FM and PM fragments from most Ly49 genes including Ly49A
displayed no detectable promoter activity in D2 NK cells
(Figure 5B). The only fragments that displayed measurable, albeit
low, activity were the FM and PM fragments from the Ly49B and
Ly49E genes. Similarly, the various uE2 fragments from the
Figure 3. Expression of Ly49 genes in various cells. A. Different sublines of RMA EL4 cells were stained with JR9 anti-Ly49A and 4D11 anti-
Ly49G mAbs (red lines) or medium (black lines) followed by AF647-conjugated secondary antibody. B. RT-PCR analysis of Ly49 transcripts in various
cell lines. cDNA prepared from equal numbers of cells was amplified using forward primers located in exon 1, exon 2, or exon 4 together with
appropriate reverse primers that in combination gave specific amplification of the relevant Ly49. The identity of the Ly49A exon 1 and Ly49G exon 1
amplimers in RMA/E3 cells was confirmed by cloning and sequencing, as was the unexpected presence of Ly49A, G, and Q transcripts in P815 cells,
and of Ly49Q transcripts in NS0 cells. C. D
2 NK cells were stained with mAbs against the Ly49s shown (red lines) or with medium (black lines).
doi:10.1371/journal.pone.0018475.g003
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PLoS ONE | www.plosone.org 7 March 2011 | Volume 6 | Issue 3 | e18475Figure 4. Promoter activity of Ly49 gene fragments in EL4 cells. A. Schematic diagram of the gene fragments tested for promoter activity,
namely the PM and FM fragments from the upstream region, the uE2 fragments from the region upstream of exon 2, and the full length ,2.3 kb
fragments that run from the start of the FM fragments to various positions around the start of exon 2. B–D. The RMA/E3 subline of EL4 cells was
transfected with pGL4 plasmids containing no insert (0), the HSV promoter, or various Ly49 gene fragments, as follows: B. FM (dark blue bars) and PM
(light blue bars) fragments from the upstream region of the Ly49 genes shown. C. The Ly49A FM fragment or fragments of various length extending
upstream from the translational start codon in exon 2 of various Ly49 genes. Numbers show the distance of the start and end of each fragment from
the start codon, and the diagrams provide a graphical representation of the fragments with intron 1 unshaded and exon 2 in red. D. The FM
fragments from the Ly49A and Ly49G genes, or ‘‘full length’’ fragments of various length beginning at the same upstream position as the FM
fragments and ending at various positions in exon 2. Numbers show the distance of the start point from the exon1/intron1 boundary, and the
distance of the end point from the translational start codon, a negative value meaning upstream and a positive value meaning downstream of the
start codon. In the +97 constructs the Ly49 start codon would be in frame with the luciferase start codon, in the +98 constructs it would be out of
frame. The diagrams show a graphical representation of the fragments with exon 1 in blue, intron 1 unshaded, and exon 2 in red. In all cases,
luciferase activity is expressed as a percentage of that observed with the HSV promoter.
doi:10.1371/journal.pone.0018475.g004
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in D
2 NK cells (not shown). Finally, to test the possibility that
promoter activity in the upstream region of Ly49 genes might be
detectable in immature NK cells we transfected the FM and PM
fragments of various Ly49 genes into the immature NK cell lines
LNK and I2/22. However, the pattern of results was similar to that
obtained with D
2 cells, most upstream fragments having little or no
detectable promoter activity (Figure 5C and Figure 5D).
Promoter activity of Ly49B and Ly49Q upstream regions
Previous studies have shown that Ly49B and Ly49Q are mainly
expressed in myeloid cells [14,15], and this was confirmed in the
present study by RT-PCR analysis which showed the presence of
Ly49B and Ly49Q transcripts in the macrophage lines J774 and
RAW264, and in the dendritic cell lines FSDC [36] and DC2.4
[37] (Figure 3B). To determine whether the upstream regions of
the Ly49B and Ly49Q genes have selective promoter activity in
such cells, appropriate constructs were transfected into these
myeloid cell lines and into a number of non-myeloid cell lines.
Ly49A FM and PM upstream fragments were devoid of activity in
all of these cell lines (Figure 6). By contrast, Ly49Q FM and PM
fragments displayed activity comparable to that of the positive
control HSV promoter in the FSDC and DC2.4 dendritic cell
lines. They also displayed moderate activity in the J774 and
RAW264 macrophage lines and in the P815 mastocytoma line
that like FSDC and DC2.4 express Ly49Q transcripts, but
displayed negligible activity in the A20 and NS0 B cell lines
despite the fact that NS0 cells were unexpectedly found to express
high levels of endogenous Ly49Q transcripts (Figure 3B). Thus,
although the upstream region of Ly49Q contains promoter activity
that can be detected in various cell lines, this activity does not
correlate precisely with the expression of the endogenous Ly49Q
genes.
The Ly49B FM fragment displayed striking activity, 4–6 fold
higher than that of the HSV promoter, in the FSDC and DC2.4
cell lines, and moderate activity in the J774 and RAW264
Figure 5. Lack of correlation between promoter activity and endogenous gene expression. A. The RMA EL4 sublines shown were
transfected with pGL4 plasmids containing no insert (not shown), the HSV promoter, or the FM fragments from upstream of the Ly49A (dark blue
bars) and Ly49G (light blue bars) genes. B–D. The mature NK cell line D
2 (B), and the immature NK cell lines LNK (C) and I2/22 (D) were transfected
with pGL4 plasmids containing no insert (0), or the FM (dark blue bars) and PM (light blue bars) fragments from upstream of the Ly49 genes shown. In
all cases, luciferase activity is expressed as a percentage of that observed with the HSV promoter.
doi:10.1371/journal.pone.0018475.g005
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of Ly49B transcripts. It also displayed moderate activity in the
LNK and I2/22 immature NK cell lines (Figure 5), which
unexpectedly have been found to express Ly49B transcripts [15],
and in some cell lines that lacked detectable Ly49B transcripts,
including P815 and A20 cells (Figure 6), and D
2 cells (Figure 5).
To explore in more detail the promoter activity found in the
upstream region of the Ly49B gene, a variety of fragments was
examined for promoter activity in FSDC cells. Extending the
Ly49B FM (448-12) fragment upstream by 37 bp (485-12) slightly
increased its activity (Figure 7), but extending it another 35 bp
upstream (520-12) to just before the start of the large LINE
sequence greatly reduced its activity (P=6.1610
26). This 35 bp
sequence, CTTAGTTTAACAGTTAAAAAAAAAGAACTTTA
ACA, located at the 59 end of the ,120 bp upstream sequence
that is unique to Ly49B, may therefore contain a powerful
repressor site. Surprisingly, extending the fragment further
upstream, into the LINE region (B-647-12, B-660-12), restored
high promoter activity, indicating a complex interplay of
regulatory elements in this region of the Ly49B gene. Conversely,
analysis of truncated PM fragments revealed that core promoter
activity resided in an ,200 bp region (B-299-95) whose 39 end was
just downstream of the major TSS. When this fragment was
truncated by a further 15 bp at its 39 end, so that only the first of
the two Inr-like sequences remained (B-299-110), promoter
activity was markedly reduced (P=0.002). Further truncation that
removed both Inr-like sequences (B-299-134) reduced activity to
low levels (P=3.9610
29). More importantly, mutation of the two
A residues that comprised the actual TSSs within the two Inr-like
sequences to G residues (B-448-Inr-GG) essentially eliminated
promoter activity. Truncation of the B-299-95 fragment at its 59
end also reduced activity: removal of the first 51 bp (B-248-95)
reduced activity significantly (P=0.01), and removal of the first
86 bp (B-213-95) reduced activity markedly (P=7.0610
25).
Finally, with a view to eventually identifying the transcription
factors that control the expression of Ly49B, we examined
fragments from the upstream region of the putative rat orthologue
of Ly49B, Ly49i8. However, as shown at the bottom of Figure 7,
Brat-415-12 and Brat-284-12 fragments had much lower activity
than the corresponding FM and PM fragments of the mouse
Ly49B gene (P=0.02 and 0.002 respectively), indicating that the
key transcription binding sites in the Ly49B gene are not conserved
in the rat Ly49i8 gene.
Discussion
In recent years the traditional model of vertebrate gene
expression in which transcripts originate from fixed positions
approximately 30 bases downstream of promoters containing
TATA boxes has largely been abandoned in the light of genome
wide analyses that have revealed that transcription occurs much
more extensively than previously envisaged, that transcriptional
units often do not have sharply defined starting points, that genes
often contain multiple widely separated TSS clusters, and that
upstream regulatory regions frequently lack TATA boxes and/or
Inr sequences [38,39,40,41,42,43,44]. In particular, the use of
Figure 6. Analysis of promoter activity in the upstream region of the Ly49B and Ly49Q genes. pGL4 plasmids containing no insert (0), the
HSV promoter, or the FM (dark blue bars) and PM (light blue bars) fragments from the upstream regions of the Ly49A, B, and Q genes were
transfected into the DC lines FSDC and DC2.4, the macrophage lines J774 and RAW264, the mastocytoma P815, and the B cell lines A20 and NS0.
Luciferase activity was calculated as a percentage of that observed with the HSV promoter. Note the different scale used for the DC lines.
doi:10.1371/journal.pone.0018475.g006
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efficiently capture the 59 ends of transcripts has revealed that
although transcriptional initiation of vertebrate genes is sometimes
concentrated in a narrow window with a single dominant start site,
it is more often spread across a broad window spanning .50 bases
[38,39,40,44].
The cap-specific analysis of Ly49 TSSs described here revealed
a striking differential use of these two patterns: Ly49B and Ly49Q
gene expression in myeloid cells, activating Ly49D and Ly49H gene
expression in NK cells, Ly49F gene expression in activated T cells,
and to a lesser extent Ly49E gene expression in vivo, occurs
predominantly in a narrow window in the middle of a conserved
pyrimidine rich region ,110 nucleotides upstream of the exon1/
intron1 boundary that has the consensus sequence ttctgcCTttcttctt
(actual start sites shown in upper case). The Ly49B and Ly49Q
genes also have a second TSS 9 bases further upstream. The
finding of, and the location of, dominant narrow TSSs in this
subset of Ly49 genes is consistent with several other studies. Firstly,
3 of the 5 TSSs identified in the Riken mouse genome cap-trapper
project for this set of genes (shown by green-shaded nucleotides in
Figure 1), namely those for Ly49B (AK017140), Ly49Q
(AK080021), and Ly49D (AK080171), correspond to the domi-
nant sites found in the present study. Interestingly, the single
Ly49A sequence found in the Riken project (AK080158)
corresponds to the most frequently used Ly49A TSS found in
the present study, which is only one base downstream from the
Ly49A TSS in EL4 cells identified by Kubo et al [16] using RNase
protection and primer extension. Secondly, in the Riken mouse
genome CAGE project [45] only one Ly49 gene, Ly49B, generated
a useful number of tags, 33. Of these, 14 had start sites within the
above described pyrimidine-rich region, 5 of which corresponded
to the downstream TSS identified in the present study, and 4 to
the upstream TSS. Finally, a recent RACE analysis of Ly49H
found the same dominant TSS as in the present study [13].
Although genes using narrow transcriptional windows are more
likely to be associated with nearby TATA boxes [40,44], none of
the subset of Ly49 genes having dominant narrow TSSs contains a
site within the first 100 nucleotides upstream that matches the
position weighted TATA box matrix in the JASPAR database. By
contrast, the two adjacent TSSs in Ly49B and the upstream TSS in
Ly49Q match exactly the canonical Inr consensus sequence
YYANWYY [46], and show the highest scores against the
Figure 7. Mapping of promoter activity in the upstream region of the Ly49B gene. pGL4 plasmids containing no insert (0), or various
fragments from the upstream region of the Ly49B gene were transfected into FSDC cells. Luciferase activity was calculated as a percentage of that
observed with the B-299-12 PM fragment. Numbers show the distance of the start and end of each fragment from the exon1/intron1 boundary, and
the diagrams provide a graphical representation of the fragments: dark blue, exon 1 (defined as the region downstream of the dominant
transcription initiation site); unshaded, region homologous to that found in the same position in other Ly49 genes; purple, region unique to Ly49B
(see Figure 1); green, LINE repeat sequence. The B-448-Inr-GG fragment was identical to the B-448-12 fragment but with the two A residues that form
the dominant TSSs of the endogenous gene mutated to G residues (shown by a red star). In a separate series of experiments the activity of fragments
from the putative rat orthologue of Ly49B, Ly49i8, (light blue bars) was compared to that of the equivalent FM (B-448-12) and PM (B-299-12)
fragments of the mouse Ly49B gene. Histograms show the mean values obtained in 3–8 independent experiments with each construct, error bars
showing the SEM where this was big enough to display.
doi:10.1371/journal.pone.0018475.g007
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of sequences displayed in Figure 1A. The Ly49B gene also
possesses a precisely positioned consensus DPE promoter element,
AGACC [46], 28–32 bp downstream of the dominant TSS. In
addition, ,30 bp upstream of the Ly49B TSS is a TA-rich region
preceded by CG-rich region that has some resemblance to BRE-
TATA elements [46]. However, the significance of these
observations is unclear because (a) the corresponding dominant
start sites in other Ly49 genes match neither the Inr consensus
sequence nor the JASPAR matrix due to an absence of the central
A residue of the motif, (b) the canonical DPE sequence is also
present in Ly49E, H, and Q but not Ly49D or F, (c) multiple
relatively high scoring matches to the JASPAR Inr, DPE, and
BRE matrices are found throughout the exon 1 sequences of each
gene, (d) whole genome analysis shows that even in TATA-less
genes many start sites do not conform to Inr sequences [40], (e) the
frequency of these motifs in randomized sequences is remarkably
high [48].
In striking contrast, transcript initiation in the inhibitory
‘‘missing self’’ Ly49 genes occurred in several broad transcriptional
regions located in at least three widely separated locations, namely
upstream of the exon1/intron1 boundary, upstream of exon -1b,
and around the intron1/exon2 boundary. These findings are
consistent with a previous study which showed a wide dispersal of
TSSs in the upstream region of the Ly49A gene and around the
intron1/exon2 boundary of the Ly49G gene [18]. However, our
study has extended these findings by revealing that most, and
probably all, Ly49 genes can initiate transcripts in the intron1-
exon2 region, and that Ly49A initiates a high proportion of
transcripts at this location. So too does Ly49E, at least in NK cells
cultured in vitro in IL2. An unexpected finding was that transcripts
could be initiated from downstream of the translational start codon
in exon 2, and even from downstream introns and exons. The
frequency of this latter event was almost certainly underestimated
due to the fact that the reverse RACE primers were not positioned
at the 39 ends of the genes. Even so, at least in the case of Ly49G it
was clearly relatively common, 13/59 (22%) of Ly49G RACE
cDNAs having start points downstream of exon 2. Initiation from
sites downstream of the start codon in exon 2 was particularly
common in Ly49E, 68/131 (52%) of transcripts from cultured NK
cells being of this type. In Ly49E and most other Ly49 genes the
first in-frame ATG downstream of the normal translation
initiation codon is in exon 4, so transcripts generated from these
sites would yield proteins that could not enter the ER and would
presumably be non-functional.
Although the positions of the TSSs in the intron1-exon2 region
appeared to be distributed largely at random, there was in fact a
remarkable bias favouring A as the start base. Amongst all Ly49
genes, 145/204 (71%) of transcripts that initiated in this region
began with an A, compared with an overall regional frequency of
A residues of 31% (P=1.2610
227). Counteracting this, there was
a marked under representation of C and T as start residues
(P=1.9610
210 and 1.7610
212 compared to the regional
frequencies). The same highly significant biases persisted even
when Ly49E, the only Ly49 to have a dominant TSS in this region,
was removed from the analysis, or when start sites were
enumerated without any weighting for the number of transcripts
at each site. These biases in starting bases are qualitatively similar,
but quantitatively much more pronounced, than reported in a
genome wide survey in humans [38], and in a genome wide survey
in mice which revealed a strong bias for purine start sites [40]. By
contrast, the start bases used by transcripts in the exon 1 region did
not show significant base biases. Interestingly, none of the Ly49
genes contains an in-frame ATG triplet downstream of the
dominant TSS region in exon 1 nor in the most actively
transcribed regions at the 39 ends of intron 1, nor does Ly49I
contain an ATG triplet in exon -1b, making it highly likely that the
first in-frame ATG triplet in exon 2 is exclusively used as the
translation initiation codon regardless of the point upstream at
which transcription is initiated.
The key data obtained in this study concerning the promoter
activity of Ly49 gene fragments in various cells and its relationship
to Ly49 gene expression in those cells is summarized in Figure 8.
Two situations in which there is a lack of concordance between the
promoter activity of transfected fragments and the expression of
the endogenous gene were identified. Those highlighted in green
are where promoter activity occurred in the absence of detectable
expression of the endogenous gene. Such situations could occur if
the transfected cells expressed some or all of the relevant
transcription factors but also expressed repressive factors that
bound to sites not present in the transfected gene fragment or if the
endogenous gene was in a closed chromatin configuration. Those
highlighted in red are where promoter activity was absent in cells
that expressed the endogenous gene. Such cells must clearly
express all of the required transacting factors, and the absence of
promoter activity in such cells demonstrates that the tested
fragment by itself does not comprise a functional promoter.
The only Ly49 gene region tested that showed promoter activity
consistent with a role in the expression of the endogenous gene was
the upstream region of the Ly49B gene, and in particular an
,200 bp fragment whose 39 end contained the dominant TSS.
This fragment was active in all Ly49B-expressing cells, most
notably in dendritic cell lines where its activity was many fold
greater than the HSV positive control promoter. The region
upstream of the Ly49Q gene also possessed significant promoter
activity in most Ly49Q-expressing cells, but not in Ly49Q-
expressing NS0 cells. By contrast, the corresponding regions from
most other Ly49 genes displayed little or no promoter activity in
relevant cells. The main exception to this rule was that fragments
from upstream of the Ly49A gene often displayed high activity in
certain EL4 sublines in agreement with previous reports
[17,19,21]. However, they lacked activity in the Ly49A-expressing
ham2 subline of EL4 and, most importantly, upstream fragments
from neither the Ly49A gene nor other Ly49 genes displayed any
significant promoter activity in the D
2 NK cell line that expressed
multiple members of the Ly49 family at high levels, including
Ly49A. Coupled with the absence of a dominant TSS downstream
of the putative Ly49A promoter and the finding from RACE
analysis that transcripts could be initiated internally throughout
the length of the putative core (PM) Ly49A promoter fragment, it
appears likely that the high promoter activity of Ly49A upstream
fragments in some EL4 sublines is caused by spurious transcription
factor expression in EL4 sublines that is unrelated to the
expression of the endogenous gene or to the physiological control
of Ly49 gene expression in NK cells. Similarly, no significant
promoter activity could be detected in fragments of various sizes
surrounding the commonly used transcription initiation region in
intron1/exon 2. Taken together, there appears to be no evidence
for the existence of classical promoters with significant tissue
specific activity in the so-called Pro2 and Pro3 regions [23] of the
Ly49 genes expressed in lymphoid cells.
Instead, our studies showed a striking and consistent difference
in the pattern of transcriptional initiation between those Ly49
genes that are expressed in a stochastic manner (A, C, E, G, and I)
and those that are probably not (B, D, H, and Q). Intriguingly, the
former genes all possess a conserved upstream Pro1 region,
whereas the latter genes either lack a recognizable Pro1 region
(Ly49B and Ly49Q) or have a substantially different and apparently
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unpublished data). Direct evidence for the importance of this
region is provided by the finding that it forms a DNase I
hypersensitivity site in vivo, and its deletion altered the pattern of
expression of an Ly49 genomic transgene [49]. It has been
suggested that Pro1 acts as a bidirectional promoter in immature
NK cells, and that when transcription is initiated in the forward
direction it neutralizes a repressor site upstream of Pro2 that allows
transcription to transfer to Pro2 in mature NK cells [24]. Our
finding that transcription in Pro1-containing genes is initiated
from multiple widely dispersed regions that lack defined promoter
or repressor sites suggests that this model is not correct. Instead we
suggest that Pro1 acts by increasing the probability of stable
transcription being established from multiple favoured regions
throughout the gene, some of which, as strikingly seen in the case
of Ly49E, may reside downstream of the translational start codon.
According to this model, the Pro1 element acts as a developmen-
tally programmed enhancer. Stochastic Ly49 gene expression
occurs if this element is able to stabilize transcription from an
appropriate downstream site within a developmentally pro-
grammed time window, by physically interacting with that site
and/or facilitating the binding of transcription factors there.
Failure to stabilize any site within the gene or the selection of an
inappropriate site downstream of the translational start codon
results in a non-productive allele in mature NK cells. The
distinctive Pro1 region found in the genes encoding activating
Ly49s such as Ly49D and H may preferentially stabilize
transcription from the conserved default initiator region in exon
1 thereby reducing the degree of stochastic expression [12] and
increasing the probability of biallelic expression [13]. Transcrip-
tion from Pro1 itself may be needed to open up the gene to
transcription factors, or may simply indicate that it is another
favoured initiation region.
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